The Psychedelic Podcast

SSRIs, Psychedelics, & Rethinking Mental Health Treatment - Robert Whitaker

Aug 24, 2026
Robert Whitaker, investigative journalist and author of Anatomy of an Epidemic, critiques modern psychiatric practice. He traces how the chemical imbalance story took hold, explores long-term outcomes of antidepressant use, and examines SSRI withdrawal versus recurrence. He warns about psychedelic medicalization and highlights the importance of ritual, community, and preserving personal agency in mental health care.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
ADVICE

Train Practitioners On SSRI Deprescribing Before Psychedelics

  • Prepare clinicians to bridge the gap between prescribing and psychedelic readiness by learning structured tapering and collaboration.
  • Paul Austin promotes SSRI Deprescribing training covering screening, tapering, withdrawal vs relapse, and prescriber coordination.
INSIGHT

Developed Countries Show Worse Long Term Outcomes

  • Long-term outcomes for schizophrenia worsened in developed countries where maintenance drug use was highest.
  • WHO studies found better recovery in developing countries that used antipsychotics only acutely, not chronically.
INSIGHT

Antipsychotics Can Induce Dopamine Hypersensitivity

  • Antipsychotics trigger compensatory brain changes that increase dopamine sensitivity.
  • Blocked receptors produce presynaptic over-release and postsynaptic receptor upregulation, creating long-term vulnerability to psychosis.
Get the Snipd Podcast app to discover more snips from this episode
Get the app